Fujing Holdings (2497) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
14 Oct, 2026Executive summary
FY2025 revenue rose 4.8% to RMB191.0m and net profit increased to RMB63.4m from RMB51.8m, supported by higher sales volumes, stronger gross margin and an ECL reversal.
Three cultivation facilities were under construction at year-end, with completion expected from September to October 2026.
Financial highlights
Revenue was RMB191.0m versus RMB182.2m in FY2024; gross profit rose to RMB84.5m from RMB77.3m.
Net profit was RMB63.4m versus RMB51.8m; total comprehensive income was RMB63.2m versus RMB52.3m.
Operating profit was RMB67.5m versus RMB53.0m; FY2025 had no listing expenses, compared with RMB8.4m in FY2024.
Finance costs increased to RMB4.1m from RMB1.2m, mainly reflecting higher bank borrowing interest.
Basic and diluted EPS were RMB0.13 versus RMB0.11.
Outlook and guidance
Growth plans prioritize cultivation capacity, entry into new geographical markets, a dedicated organic-substrates facility and IT-system upgrades.
Replacement Xi’an and Phase II Beijing facilities are expected to complete in September 2026; Yaozhuang is expected to complete in October 2026.
The planned organic-substrates facility and ERP-system upgrade have use-of-proceeds timelines extended to December 2026.
Latest events from Fujing Holdings
- Higher pot sales lifted revenue, but listing costs cut H1 net profit to RMB14.877m.2497
H1 2024 - Higher volumes lifted sales and profit, but costs and ECL pressure narrowed margins.2497
H2 2024 - Revenue rose, but higher expenses, ECL and lower fair-value gains cut H1 profit.2497
H1 2026 - Beijing-led sales growth lifted profit as expansion increased borrowing and gearing.2497
H1 2025